Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11804490rdf:typepubmed:Citationlld:pubmed
pubmed-article:11804490lifeskim:mentionsumls-concept:C0022023lld:lifeskim
pubmed-article:11804490lifeskim:mentionsumls-concept:C1704241lld:lifeskim
pubmed-article:11804490lifeskim:mentionsumls-concept:C0699857lld:lifeskim
pubmed-article:11804490lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:11804490lifeskim:mentionsumls-concept:C1948027lld:lifeskim
pubmed-article:11804490lifeskim:mentionsumls-concept:C1511572lld:lifeskim
pubmed-article:11804490pubmed:issue4lld:pubmed
pubmed-article:11804490pubmed:dateCreated2002-1-23lld:pubmed
pubmed-article:11804490pubmed:abstractTextThis paper reports a pH-dependent H2-activation [H2 (pH 1-4) --> H+ + H- (pH -1) --> 2H+ + 2e-] promoted by CpIr complexes [Cp = eta5-C5(CH3)5]. In a pH range of about 1-4, an aqueous HNO3 solution of [CpIr(III)(H2O)3]2+ (1) reacts with 3 equiv of H2 to yield a solution of [(CpIr(III))2(mu-H)3]+ (2) as a result of heterolytic H2-activation [2[1] + 3H2 (pH 1-4) --> [2] + 3H+ + 6H2O]. The hydrido ligands of 2 display protonic behavior and undergo H/D exchange with D+: [M-(H)3-M]+ + 3D+ <==>[M-(D)3-M]+ + 3H+ (where M = CpIr). Complex 2 is insoluble in a pH range of about -0.2 (1.6 M HNO3/H2O) to -0.8 (6.3 M HNO3/H2O). At pH -1 (10 M HNO3/H2O), a powder of 2 drastically reacts with HNO3 to give a solution of [CpIr(III)(NO3)2] (3) with evolution of H2, NO, and NO2 gases. D-labeling experiments show that the evolved H2 is derived from the hydrido ligands of 2. These results suggest that oxidation of the hydrido ligands of 2 [[2] + 4NO3- (pH -1) --> 2[3] + H2 + H+ + 4e-] couples to reduction of NO3- (NO3- --> NO2- --> NO). To complete the reaction cycle, complex 3 is transformed into 1 by increasing the pH of the solution from -1 to 1. Therefore, we are able to repeat the reaction cycle using 1, H2, and a pH gradient between 1 and -1. A conceivable mechanism for the H2-activation cycle with reduction of NO3- is proposed.lld:pubmed
pubmed-article:11804490pubmed:languageenglld:pubmed
pubmed-article:11804490pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11804490pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:11804490pubmed:monthJanlld:pubmed
pubmed-article:11804490pubmed:issn0002-7863lld:pubmed
pubmed-article:11804490pubmed:authorpubmed-author:OgoSeijiSlld:pubmed
pubmed-article:11804490pubmed:authorpubmed-author:NakaiHidetaka...lld:pubmed
pubmed-article:11804490pubmed:authorpubmed-author:WatanabeYoshi...lld:pubmed
pubmed-article:11804490pubmed:issnTypePrintlld:pubmed
pubmed-article:11804490pubmed:day30lld:pubmed
pubmed-article:11804490pubmed:volume124lld:pubmed
pubmed-article:11804490pubmed:ownerNLMlld:pubmed
pubmed-article:11804490pubmed:authorsCompleteYlld:pubmed
pubmed-article:11804490pubmed:pagination597-601lld:pubmed
pubmed-article:11804490pubmed:dateRevised2003-10-31lld:pubmed
pubmed-article:11804490pubmed:year2002lld:pubmed
pubmed-article:11804490pubmed:articleTitlepH-dependent H2-activation cycle coupled to reduction of nitrate ion by CpIr complexes.lld:pubmed
pubmed-article:11804490pubmed:affiliationInstitute for Molecular Science, Myodaiji, Okazaki 444-8585, Japan.lld:pubmed
pubmed-article:11804490pubmed:publicationTypeJournal Articlelld:pubmed